Sign in

CIK 0001668243 · Non-accelerated filer<br>Smaller reporting company

UroGen Pharma Ltd.

Sign in to watch
Ticker
URGN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Israel
Entity type
operating
Phone
972 9 770 7601
Business address
9 HA'TA'ASIYA ST, RA'ANANA, Israel, 4365007
  1. 4 Insider Changes in Ownership
  2. 6-K Event Report of Foreign Issuer
  3. SC 13G Stake Amended Statement of Ownership
  4. 6-K Event Report of Foreign Issuer
  5. 6-K Event Report of Foreign Issuer
  6. S-8 Other Securities Offered to Employees in Benefit Plans
  7. 6-K Event Report of Foreign Issuer
  8. 6-K Event Report of Foreign Issuer
  9. 3 Insider Initial Statement of Ownership
  10. SC 13G Stake Amended Statement of Ownership
  11. 6-K Event Report of Foreign Issuer
  12. S-8 Other Securities Offered to Employees in Benefit Plans
  13. SC 13D Stake Beneficial Ownership Report
  14. 6-K Event Report of Foreign Issuer
  15. 424B4 Offering Prospectus
  16. CT ORDER Other Confidential Order
  17. EFFECT Other Notice of Effectiveness
  18. F-1MEF Other F-1MEF
  19. CERTNAS Other Certification by the Nasdaq Stock Market
  20. CORRESP Other Correspondence Between Filers and SEC Staff

Page 28 of 30 · 583 filings